Legal & General Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.34M Buy
57,919
+5,752
+11% +$331K ﹤0.01% 1742
2025
Q1
$3.04M Buy
52,167
+2,196
+4% +$128K ﹤0.01% 1757
2024
Q4
$4.02M Buy
49,971
+1,080
+2% +$87K ﹤0.01% 1686
2024
Q3
$3.92M Buy
48,891
+3,839
+9% +$308K ﹤0.01% 1684
2024
Q2
$2.75M Buy
45,052
+299
+0.7% +$18.3K ﹤0.01% 1798
2024
Q1
$2.21M Buy
44,753
+1,172
+3% +$57.9K ﹤0.01% 1899
2023
Q4
$1.83M Buy
43,581
+5,114
+13% +$214K ﹤0.01% 1995
2023
Q3
$1.26M Buy
38,467
+4,611
+14% +$151K ﹤0.01% 2103
2023
Q2
$1.2M Buy
33,856
+26,796
+380% +$947K ﹤0.01% 2147
2023
Q1
$201K Buy
7,060
+217
+3% +$6.16K ﹤0.01% 2590
2022
Q4
$284K Buy
6,843
+295
+5% +$12.3K ﹤0.01% 2485
2022
Q3
$271K Sell
6,548
-2,747
-30% -$114K ﹤0.01% 2510
2022
Q2
$304K Buy
9,295
+8,585
+1,209% +$281K ﹤0.01% 2491
2022
Q1
$25K Hold
710
﹤0.01% 3178
2021
Q4
$18K Buy
+710
New +$18K ﹤0.01% 3311